Latest filing published 06 Jul 2026 for Zai Lab Ltd, €29k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +19.8%Entry US$19.35 · Close 16 Oct 2026 US$23.19
- +28.2%Entry US$18.09 · Close 16 Oct 2026 US$23.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard Gaynor: trading record in brief
Richard Gaynor, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Neon Therapeutics, Inc., Alkermes plc. and Zai Lab Ltd. The record holds 25 filings, for trades running from 27 February 2019 to 1 July 2026.
Market trades split into 2 purchases (€58k) and 5 sales (€204k). Taken together, the sales exceed the purchases by €146k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 10 share grants and 7 option exercises. Since January 2026: 2 purchases and no sales on the market.
Most recently, on 6 July 2026, the filings show an open-market purchase worth €29k in Zai Lab Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard Gaynor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,736 shares@ US$19.050.0011% mcap4.5% of flowAmerican Depositary SharesSEC:0000905148-26-003169:0Canonical exit: 29 Sept 2026 (T+90)
- 1,475 shares@ US$36.950.0007% mcap100.0% of flowOrdinary SharesSEC:0001520262-26-000084:1
- 6,142 sharesOrdinary SharesSEC:0001520262-26-000084:0
- 1,731 shares@ US$18.910.0012% mcap4.4% of flowAmerican Depositary SharesSEC:0000905148-26-001398:0Canonical exit: 15 Jun 2026 (T+90)
- 10,831 shares0American Depositary SharesSEC:0000905148-25-002217:0
- 8,013 sharesOrdinary SharesSEC:0001127602-25-016198:0
- 2,500 shares@ US$35.0712.8% of flowAmerican Depositary SharesSEC:0000905148-25-000873:0
- 2,500 shares@ US$19.506.8% of flowAmerican Depositary SharesSEC:0000905148-24-002519:0
- 6,104 sharesOrdinary SharesSEC:0001127602-24-019594:0
- 21,253 shares0American Depositary SharesSEC:0000905148-24-001753:0
- 5,957 sharesOrdinary SharesSEC:0001127602-23-020547:0
- 18,903 shares@ US$26.4571.4% of flowAmerican Depositary SharesSEC:0000950170-23-031095:0
- 7,585 sharesOrdinary SharesSEC:0001127602-22-017637:0
- 5,578 sharesOrdinary SharesSEC:0001127602-21-030302:0
- 8,912 shares0Ordinary SharesSEC:0000899243-21-045487:0
- 6,104 shares0Ordinary SharesSEC:0001127602-21-017788:0
- 210,410 sharesCommon StockSEC:0001694187-20-000065:0
- 5,625 shares@ US$1.508.3% of flowCommon StockSEC:0001694187-20-000029:0
- 5,465 shares@ US$1.518.2% of flowCommon StockSEC:0001694187-20-000012:0
- 65,000 shares0Common StockSEC:0001694187-20-000006:0
- 20,000 shares@ US$1.3726.8% of flowCommon StockSEC:0001694187-19-000080:0
- 23,000 shares@ US$1.3129.5% of flowCommon StockSEC:0001694187-19-000080:1
- 22,322 shares@ US$1.2427.1% of flowCommon StockSEC:0001694187-19-000080:2
- 75,000 shares0Common StockSEC:0001694187-19-000077:0
- 57,500 shares0Common StockSEC:0001694187-19-000013:0
25 of 25 declarations
